Percutaneous transmural arterial bypass in routine practice: Our 2-year experience
Journal of Vascular Surgery · 2026-09 · 84 (3) · 716-723
DOI: 10.1016/j.jvs.2026.05.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2026-09. Verfasst von Maarten Bruggeman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Philadelphia College of Osteopathic Medicine, Philadelphia, PA. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Femoral Artery, Endovascular Procedures, Popliteal Artery. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES Percutaneous transmural arterial bypass (PTAB) (Endologix) integrates principles of open surgical bypass with minimally invasive endovascular techniques to treat long-segment occlusions of the superficial femoral (SFA) and popliteal arteries. The DETOUR1 trial demonstrated favorable 1-year patency outcomes, with primary (PPR), primary-assisted (PAPR), and secondary patency rates (SPR) of 81±4%, 82±4% and 90±3%, respectively. Similarly, the DETOUR II trial reported acceptable 2-year patency, with PPR of 79±5%, PAPR of 78±5%, and SPR of 86±4%. However, outcomes of PTAB outside of the DETOUR clinical trials remain limited. METHODS A retrospective analysis of patients who underwent PTAB within our healthcare system was conducted from August 2023 until December 2025. Collected variables included patient demographics, perioperative details, and postoperative outcomes. Primary endpoints were PPR, PAPR and SPR assessed at 1, 3, 6, 12, 18 and 24 months. RESULTS A total of 49 PTAB procedures were performed in 44 patients (61.4 % male, mean age 71±7.3 years). Mean treated SFA occlusion length was 303 ± 125.1 mm. Technical success was achieved in 100% of cases, and all patients were discharged on combined oral antiplatelet and anticoagulant therapy. Mean follow-up was 312 days (range 6-788 days). Primary patency rate at 1, 3, 6 and 12 months was 97.8%, 84.6%, 60.6% and 47.6 % respectively. Corresponding PAPR was 100%, 87.2%, 69.7%, 71.4% respectively, and SPR was 100%, 100%, 90.9%, and 90.5% at the same intervals. At 18 months (n=12), only one patient had primary patency (8.3%), while PAPR and SPR were 41.7% and 83.3%, respectively. Only three patients had 24-month follow-up, all of whom had required intervention to maintain patency. Overall, 16 stent occlusions occurred, 20 patients required intervention, and two patients underwent major amputation secondary to stent occlusion. CONCLUSIONS The PTAB device in our experience was associated with lower PPR and PAPR than those reported in the DETOUR trials. These findings underscore the need for close post-procedural surveillance and timely reintervention in patients that undergo PTAB procedure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Philadelphia College of Osteopathic Medicine, Philadelphia, PA.
- Department of Surgery, Lankenau Medical Center, Wynnewood, PA.
- Lankenau Institute for Medical Research, Penn Wynne, PA.
- Division of Vascular and Endovascular Surgery, Main Line, Wynnewood, PA.
- Division of Vascular and Endovascular Surgery, Main Line, Wynnewood, PA. Electronic address: digiovanniv@mlhs.org.
Zitieren
APA
Bruggeman, M., Tsouknidas, I., Feeney, K., Fox, T., Kjelstrom, S., Meisner, R., Hirsch, H., & DiGiovanni, V. (2026). Percutaneous transmural arterial bypass in routine practice: Our 2-year experience. Journal of Vascular Surgery, 84(3), 716-723. https://doi.org/10.1016/j.jvs.2026.05.019
Vancouver
Bruggeman M, Tsouknidas I, Feeney K, Fox T, Kjelstrom S, Meisner R, et al. Percutaneous transmural arterial bypass in routine practice: Our 2-year experience. Journal of Vascular Surgery. 2026;84(3):716-723. doi:10.1016/j.jvs.2026.05.019
BibTeX
@article{Bruggeman2026,
author = {Bruggeman, Maarten and Tsouknidas, Ioannis and Feeney, Kimberly and Fox, Tyler and Kjelstrom, Stephanie and Meisner, Robert and Hirsch, Henry and DiGiovanni, Vincent},
title = {Percutaneous transmural arterial bypass in routine practice: Our 2-year experience},
journal = {Journal of Vascular Surgery},
year = {2026},
volume = {84},
number = {3},
pages = {716--723},
doi = {10.1016/j.jvs.2026.05.019}
}
EUVIMED